Last Updated : Tuesday, March 17, 2020 18:33:51

Dr REDDY’s LAB gets USFDA nod to market injection to treat severe agitation in patients with schizophrenia

HYDERABAD / PRINCETON / MUMBAI / RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Hyderabad headquartered pharmaceutical products manufacturing company Dr Reddy’s Laboratories Ltd said of having got nod from USFDA (US Food and Drugs Administration) to sell injection in US Market to treat severe agitation in patients with schizophrenia, the injection will be available in single dose vials comprising of 20 mg (milligram) / ml (milliliter) dosage.

For LONG READ, please click / log on / visit :-

In case, if the reader wishes to VERIFY the above narrated news-report, please CLICK here.


FacebookGoogle+LinkedinTwitterYouTube, Blogspot, Telegram, Instagram 


Do NOT follow this link or you will be banned from the site!